Condition
Neoadjuvant Treatment clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Neoadjuvant Treatment clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (1), Italy (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Neoadjuvant Treatment clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Feeding-jejunostomy nutrition during pre-surgery treatment for esophagus or stomach cancer | — | Pessac | Recruiting | May 13, 2026 |
| Zanzalintinib before surgery for advanced thyroid cancer | Phase 2 | Boston, Massachusetts and 4 other locations | Recruiting | May 6, 2025 |
| Impact of diet and exercise on early breast cancer treatment | — | Novara, Novara | Recruiting | Apr 15, 2025 |
| Combining Adbelimumab with Chemotherapy and Apatinib for Esophageal Cancer Treatment | Phase 2 | Hangzhou, China | Recruiting | Aug 29, 2024 |
| Comparing immunochemotherapy and chemotherapy for esophageal cancer before surgery | Phase 3 | Zhengzhou, Henan | Recruiting | Feb 21, 2020 |
All recruiting trials (5)
-
Feeding-jejunostomy nutrition during pre-surgery treatment for esophagus or stomach cancer
This study tests whether giving nutrition through a jejunostomy tube during pre-surgery (neoadjuvant) treatment helps reduce complications after surgery for malnourished people with esophageal or stomach cancer.
-
Zanzalintinib before surgery for advanced thyroid cancer
This will try zanzalintinib before surgery in adults with advanced or locally invasive thyroid cancers to shrink tumors and make surgery safer and less complex.
-
Impact of diet and exercise on early breast cancer treatment
This study is testing if adding diet and exercise to standard breast cancer treatment can help improve health and treatment outcomes for women with early-stage breast cancer.
-
Combining Adbelimumab with Chemotherapy and Apatinib for Esophageal Cancer Treatment
This study is testing a new treatment that combines Adbelimumab with chemotherapy and Apatinib to see if it can help people with esophageal cancer live longer and reduce the chances of cancer coming back after surgery.
-
Comparing immunochemotherapy and chemotherapy for esophageal cancer before surgery
This study is testing if a new combination of immunotherapy and chemotherapy can help people with esophageal cancer live longer and have better outcomes before surgery compared to standard chemotherapy.
Related topics
Quick answers
How many Neoadjuvant Treatment clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (1 trial), Italy (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.